FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称IBRAMVIBART
异名/同义词H-GAMMA1 HEAVY CHAIN HOMO SAPIENS (1-454) (VH (HOMO SAPIENS IGHV3-21*07 (88.8%) -(IGHD) -IGHJ4*01 (92.9%), CDRIMGT (8.8.17) (26-33.51-58.97-113)) (1-124) -HOMO SAPIENS IGHG1*03, G1M3, NG1M1 CH1 R120, CH3 E12, M14, 9-G1V78 CH3 L107 A114 (CH1 R120 (221) (125-222), HINGE 1-15 (223-237), CH2 (238-347), CH3 E12 (363), M14 (365), M107>L (435), N114>A (441) (348-452), CHS (453-454)) (125-454)), (227-217')-DISULFIDE WITH L-LAMBDA2 LIGHT CHAIN HOMO SAPIENS (1'-218') (VLAMBDA (HOMO SAPIENS IGLV1-40*01 (92.8%) -IGLJ1*01 (91.7%), CDR-IMGT (9.3.12) (26'-34'.52'-54'.91'-102')) (1'-112') -HOMO SAPIENS IGLC2*01 (100%) (C-LAMBDA2) (113'-218')); DIMER (233-233'':236-236'')-BISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, CELL LINE CHO-K1, GLYCOFORM ALFA
IBRAMVIBART
IBRAMVIBART [INN]
IMMUNOGLOBULIN G1 (435-LEUCINE,441-ALANINE), ANTI-(SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 SPIKE GLYCOPROTEIN RECEPTOR-BINDING DOMAIN) (HUMAN MONOCLONAL VYD2311 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL VYD2311 .LAMBDA.-CHAIN, DIMER
IMMUNOGLOBULIN G1-KAPPA, ANTI-(SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2) SPIKE (S) PROTEIN, RECEPTOR BINDING DOMAIN (RBD)), HOMO SAPIENS MONOCLONAL ANTIBODY (IBRAMVIBART)
VYD2311
VYD-2311
CAS登记号3031270-42-2
物质唯一标识(Unique Ingredient Identifier)PRC4J48944
分子式
国际化合物标识(International Chemical Identifier,InChI)
SMILES
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型 / INGREDIENT SUBSTANCE
关联数据
  • 药品国际非专利名称数据库
扩展资源
©2006-2026 Drugfuture->FDA Global Substance Registration System